FLT3 리간드 융합 단백질 및 이용 방법

본원 발명은 효과기 결여 면역글로불린 Fc 단백질, Flt3 리간드에 효과기 결여 Fc 단백질의 융합, 그리고 이들을 이용하는 방법을 제공한다. The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same....

Full description

Saved in:
Bibliographic Details
Main Authors COHEN SIVAN, KEMBALL CHRISTOPHER CHARLES, LAZAR GREGORY ALAN, SCHARTNER JILL M, LIU YICHIN, HOSSEINI IRAJ, MOUSSION CHRISTINE CARINE, BAINBRIDGE TRAVIS WILLIAM
Format Patent
LanguageKorean
Published 28.03.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 본원 발명은 효과기 결여 면역글로불린 Fc 단백질, Flt3 리간드에 효과기 결여 Fc 단백질의 융합, 그리고 이들을 이용하는 방법을 제공한다. The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
AbstractList 본원 발명은 효과기 결여 면역글로불린 Fc 단백질, Flt3 리간드에 효과기 결여 Fc 단백질의 융합, 그리고 이들을 이용하는 방법을 제공한다. The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
Author LIU YICHIN
MOUSSION CHRISTINE CARINE
COHEN SIVAN
KEMBALL CHRISTOPHER CHARLES
BAINBRIDGE TRAVIS WILLIAM
HOSSEINI IRAJ
LAZAR GREGORY ALAN
SCHARTNER JILL M
Author_xml – fullname: COHEN SIVAN
– fullname: KEMBALL CHRISTOPHER CHARLES
– fullname: LAZAR GREGORY ALAN
– fullname: SCHARTNER JILL M
– fullname: LIU YICHIN
– fullname: HOSSEINI IRAJ
– fullname: MOUSSION CHRISTINE CARINE
– fullname: BAINBRIDGE TRAVIS WILLIAM
BookMark eNrjYmDJy89L5WQwdPMJMVZ4vWzNqw0tryfPUXgzZ-vbqSsVXneveL1h45vlHQqvN_QrvJm75c0soOCGla83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRsYGBiZGppZmjsbEqQIAdgo5-w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230042596A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230042596A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:14:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230042596A3
Notes Application Number: KR20237007373
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230328&DB=EPODOC&CC=KR&NR=20230042596A
ParticipantIDs epo_espacenet_KR20230042596A
PublicationCentury 2000
PublicationDate 20230328
PublicationDateYYYYMMDD 2023-03-28
PublicationDate_xml – month: 03
  year: 2023
  text: 20230328
  day: 28
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies GENENTECH, INC
RelatedCompanies_xml – name: GENENTECH, INC
Score 3.4363883
Snippet 본원 발명은 효과기 결여 면역글로불린 Fc 단백질, Flt3 리간드에 효과기 결여 Fc 단백질의 융합, 그리고 이들을 이용하는 방법을 제공한다. The invention provides an effectorless immunoglobulin Fc protein, fusions of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title FLT3 리간드 융합 단백질 및 이용 방법
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230328&DB=EPODOC&locale=&CC=KR&NR=20230042596A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdIAq0eNNNNTTNP0gXdcaWbmGJuqgtUnmZglmSalGIK2o3s62fmEWriFWEawcSQA9sLAz4ntBx8OCIwRyUD83sJuLwuQAxiuYDXVhbrJ2UChfLt3UJsXdSgvWNge9rYyELNxcnWNcDfxd9ZzdnZ1jtIzS8IIgdKoJZmjswMrKCGNOikfdcwJ9C-lALkSsVNkIEtAGheXokQA1N2vjADpzPs7jVhBg5f6JQ3kAnNfcUiDIZuPiHGCq-XrXm1oeX15DkKb-ZsfTt1pcLr7hWvN2x8s7xD4fWGfoU3c7e8mQUU3LDy9aapogzKbq4hzh66QLvj4V6N9w5CdqixGANLXn5eqgSDQiqwnZNqCsycwPaGSVpKcpKxWSqw5rVIMTUBMsySJBlk8JkkhV9amoELxAWtrTKykGFgKSkqTZUFVrYlSXLgMAIAP52N3Q
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdIAq0eNNNNTTNP0gXdcaWbmGJuqgtUnmZglmSalGIK2o3s62fmEWriFWEawcSQA9sLAz4ntBx8OCIwRyUD83sJuLwuQAxiuYDXVhbrJ2UChfLt3UJsXdSgvWNge9rYyELNxcnWNcDfxd9ZzdnZ1jtIzS8IIgdKoJZmjswMrObATiG4sxTmBNqXUoBcqbgJMrAFAM3LKxFiYMrOF2bgdIbdvSbMwOELnfIGMqG5r1iEwdDNJ8RY4fWyNa82tLyePEfhzZytb6euVHjdveL1ho1vlncovN7Qr_Bm7pY3s4CCG1a-3jRVlEHZzTXE2UMXaHc83Kvx3kHIDjUWY2DJy89LlWBQSAW2c1JNgZkT2N4wSUtJTjI2SwXWvBYppiZAhlmSJIMMPpOk8EvLM3B6hPj6xPt4-nlLM3CBpEDrrIwsZBhYSopKU2WBFW9Jkhw4vAAHDpDH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FLT3+%EB%A6%AC%EA%B0%84%EB%93%9C+%EC%9C%B5%ED%95%A9+%EB%8B%A8%EB%B0%B1%EC%A7%88+%EB%B0%8F+%EC%9D%B4%EC%9A%A9+%EB%B0%A9%EB%B2%95&rft.inventor=COHEN+SIVAN&rft.inventor=KEMBALL+CHRISTOPHER+CHARLES&rft.inventor=LAZAR+GREGORY+ALAN&rft.inventor=SCHARTNER+JILL+M&rft.inventor=LIU+YICHIN&rft.inventor=HOSSEINI+IRAJ&rft.inventor=MOUSSION+CHRISTINE+CARINE&rft.inventor=BAINBRIDGE+TRAVIS+WILLIAM&rft.date=2023-03-28&rft.externalDBID=A&rft.externalDocID=KR20230042596A